Related by context. All words. (Click for frequent words.) 74 FOLOTYN 71 MGCD# [001] 71 CoFactor 71 picoplatin 70 CR# vcMMAE 70 Marqibo 70 HuMax CD4 69 MOZOBIL 69 sapacitabine 69 talactoferrin 69 HGS ETR1 69 PXD# 69 INCB# [001] 69 Amigal 68 Folotyn 68 ganetespib 68 L MTP PE 68 blinatumomab 68 PDX pralatrexate 68 Troxatyl 68 Ceflatonin 67 alvespimycin 67 AP# [003] 67 clofarabine 67 Panzem R NCD 67 Panzem 67 ixabepilone 67 romidepsin 67 Insegia 67 perifosine 67 HGS ETR2 67 Clolar 67 Sym# 67 REOLYSIN ® 67 amrubicin 67 EFAPROXYN 67 FavId 67 Proxinium TM 67 neratinib 67 ongoing Phase 1b 66 ponatinib 66 IMA# 66 refractory PTCL 66 TOCOSOL Paclitaxel 66 eltrombopag 66 oral ridaforolimus 66 L BLP# 66 PEG SN# 66 #D#C# 66 Azedra 66 TELINTRA 66 zanolimumab 66 obatoclax 66 HuLuc# 66 Targretin 66 anticancer compound 66 voreloxin 66 glufosfamide 66 Phase Ib study 66 IMGN# 66 deforolimus 66 entinostat 66 Zerenex 66 ADVEXIN 66 Genasense 66 IRX 2 66 Fodosine 66 OPAXIO 66 tamibarotene 65 XYOTAX TM 65 Advexin 65 Junovan 65 BAY #-# 65 phase IIb clinical 65 satraplatin 65 Chemophase 65 otelixizumab 65 tanespimycin 65 OncoVEX GM CSF 65 RIGScan CR 65 Amrubicin 65 omacetaxine 65 eniluracil 65 Pralatrexate 65 YONDELIS 65 Allovectin 7 ® 65 thymalfasin 65 PLK1 SNALP 65 lintuzumab 65 XmAb# 65 IL# PE#QQR 65 ISTODAX 65 Xanafide 65 elotuzumab 65 mapatumumab 65 mifamurtide 65 TELCYTA 65 ZYBRESTAT 65 relapsed multiple myeloma 65 enzastaurin 65 FOLOTYN ® 65 Cloretazine R VNP#M 65 rNAPc2 65 axitinib 65 Mepact 65 forodesine 65 aflibercept 65 oral prodrug 65 registrational 65 XL# [003] 65 PNP inhibitor 65 docetaxel Taxotere R 65 Clolar ® 65 AEG# 65 Ceplene 65 vosaroxin 65 vandetanib 65 HspE7 65 PrevOnco 65 Velcade bortezomib 65 Veronate 64 Personalized Immunotherapy 64 Stedivaze 64 Asentar 64 Allovectin 7 R 64 Archexin 64 tezampanel 64 INCB# [002] 64 ofatumumab 64 Xinlay 64 bafetinib 64 GALNS 64 OncoVEX 64 Tarceva TM 64 Phase #/#a trial 64 Panzem R 64 refractory chronic lymphocytic 64 CA4P 64 AzaSite Plus 64 Icatibant 64 Aurexis 64 tivozanib 64 cetuximab Erbitux ® 64 MAGE A3 ASCI 64 Dacogen injection 64 JAK inhibitor 64 mRCC 64 RSR# 64 mertansine 64 hematological cancers 64 virus HCV protease inhibitor 64 pomalidomide 64 Quinamed 64 Combidex 64 belinostat 64 Evoltra 64 confirmatory Phase III 64 ambrisentan 64 Plicera 64 Annamycin 64 tesetaxel 64 lorvotuzumab mertansine 64 vorinostat 64 OvaRex ® MAb 64 EOquin 64 PRT# 64 Evoltra TM 64 SinuNase 64 Azixa 64 TLK# 64 Triolex 64 TRISENOX 64 Zybrestat 64 trastuzumab DM1 T DM1 64 T DM1 64 PROMACTA 63 Bezielle 63 Phenoptin 63 GRN#L 63 refractory multiple myeloma 63 investigational therapies 63 adecatumumab 63 OMAPRO 63 Rescula 63 RG# [001] 63 valopicitabine 63 Nasulin 63 Traficet EN 63 Fludara 63 dirucotide 63 Reolysin 63 Alocrest 63 Avastin bevacizumab 63 investigational humanized monoclonal antibody 63 Mozobil 63 ruxolitinib 63 ELACYT 63 Promacta 63 IMC A# 63 ELND# 63 targeted antifolate 63 carfilzomib 63 HER2 positive metastatic breast 63 MGCD# [002] 63 Onrigin 63 Genasense ® 63 panitumumab 63 XL# XL# XL# 63 Glufosfamide 63 Vidaza azacitidine 63 MDV# 63 Trofex 63 refractory Hodgkin lymphoma 63 targeted radiotherapeutic 63 Genentech Roche 63 SANVAR 63 Nebido 63 AQ4N 63 Campath 63 PEG PAL 63 registrational trial 63 Azedra TM 63 methylnaltrexone 63 liposomal formulation 63 Zalbin 63 cutaneous T cell 63 Cloretazine 63 samalizumab 63 radiation sensitizer 63 alvimopan 63 Firazyr 63 Gencaro 63 LY# [003] 63 HuMax EGFr 63 GATTEX 63 Leukine ® 63 TG# [003] 63 BiTE antibody 63 lesinurad 63 brostallicin 63 Taxotere ® 63 tafamidis 63 ALN RSV# 63 Anturol 63 PROVENGE sipuleucel T 63 huC# DM4 63 orBec 63 SAR# [004] 63 prGCD 63 DAVANAT R 63 Evoltra ® 63 PROVENGE 63 Cinryze ™ 63 Civacir 63 MyVax R 63 forodesine hydrochloride 63 Bortezomib 63 metastatic renal cell carcinoma 63 IAP inhibitors 63 SUCCEED trial 63 sunitinib malate 63 custirsen 63 PrevOnco ™ 62 AZILECT R 62 autologous cellular immunotherapy 62 HRPC 62 TOCOSOL Camptothecin 62 JAK1 62 HCD# [002] 62 bendamustine 62 Perifosine 62 Vidaza 62 BRIM2 62 brentuximab vedotin 62 APF# 62 vemurafenib 62 bevacizumab Avastin 62 Tamibarotene 62 PREOS 62 lymphoma CTCL 62 LEUKINE 62 CYC# 62 maribavir 62 relapsed refractory multiple myeloma 62 RDEA# 62 nonclinical studies 62 FTY# 62 XL# XL# 62 HSP# inhibitor 62 PI3K/Akt pathway inhibitor 62 Zenvia ™ 62 MAXY G# 62 lapatinib Tykerb 62 Treanda 62 EndoTAG TM -1 62 LEP ETU 62 refractory APL 62 TREANDA 62 SILENOR TM 62 Genz # 62 PS# [001] 62 XYOTAX 62 LymphoStat B 62 Ketotransdel 62 RGB # 62 phase IIa clinical 62 Neurodex 62 elesclomol 62 Tyrima 62 TYKERB 62 oritavancin 62 Jevtana 62 investigational immunotherapy 62 bardoxolone 62 pan HDAC inhibitor 62 NPSP# 62 Exelixis compounds 62 APOPTONE 62 seliciclib 62 Phase III clinical 62 MAA submission 62 BiovaxID 62 paclitaxel Taxol ® 62 pertuzumab 62 DAVANAT 62 CYT# 62 Azedra ™ 62 Herceptin trastuzumab 62 albinterferon alfa 2b 62 MYDICAR ® 62 cintredekin besudotox 62 CEQ# 62 Gemzar ® 62 Restanza 62 initiate Phase 1b 62 Romidepsin 62 Vectibix 62 phase IIb trial 62 cancer immunotherapies 62 Vicinium TM 62 Specifid 62 selective androgen receptor modulator 62 elacytarabine 62 MEK inhibitors 62 subcutaneous formulation 62 Nexavar ® 62 Orathecin 62 TEMODAL 62 TYZEKA 62 Leukine 62 GED aPC 62 MEK inhibitor RDEA# 62 LE SN# 62 zalutumumab 62 teduglutide 62 Ambrisentan 62 HGS# 62 Neuradiab 62 cell lymphoma CTCL 62 Atiprimod 62 temsirolimus 62 ridaforolimus 62 Alpharadin 62 Vilazodone 62 KRN# 62 UPLYSO 62 ASONEP 62 pixantrone 62 OHR/AVR# 62 metaglidasen 62 MEPACT 62 REOLYSIN 62 Omigard 62 Urocidin 62 ZOLINZA 62 cetuximab Erbitux 62 OXi# 62 Dacogen 62 IIa trial 62 trabectedin 62 Phase Ib 62 StemEx R 62 romiplostim 61 Menerba 61 Romiplostim 61 BCX# 61 BLA filing 61 OvaRex R 61 Cintredekin Besudotox 61 investigational monoclonal antibody 61 Cinryze TM 61 vinorelbine 61 proteasome inhibitor 61 Cardio Vascu Grow 61 PROPEL trial 61 Fibrillex TM 61 urocortin 2 61 Bicifadine 61 oral Xeloda 61 PDE4 inhibitor 61 sorafenib Nexavar 61 depsipeptide 61 Cellegesic 61 AMD# [003] 61 BENLYSTA 61 dacetuzumab 61 bevacizumab Avastin ® 61 ASA# 61 Phase 1b trial 61 Neo Urinary Conduit 61 bazedoxifene 61 DOS# 61 Panzem NCD 61 Iluvien ® 61 celgosivir 61 telaprevir VX 61 cangrelor 61 LibiGel ® 61 R sorafenib tablets 61 hematological malignancies 61 nilotinib 61 Xcytrin 61 daclizumab 61 VEGF Trap 61 nab paclitaxel 61 modified glutathione analog 61 HuMax CD# 61 Vasovist 61 thalidomide Thalomid 61 torezolid phosphate 61 castrate resistant prostate cancer 61 erlotinib Tarceva ® 61 Nanobody 61 Telintra 61 Hematide ™ 61 indacaterol 61 OncoGel 61 NEUMUNE 61 BrachySil TM 61 Fablyn 61 castration resistant prostate cancer 61 Omnitarg 61 BiovaxID TM 61 Phase 2b trial 61 ezogabine 61 MyVax 61 CBLC# 61 Abiraterone acetate 61 PANVAC VF 61 Vandetanib 61 Symadex 61 Zolinza 61 SCH # 61 Virulizin R 61 Androxal ® 61 LymphoStat B TM 61 generation purine nucleoside 61 vidofludimus 61 Aviptadil 61 Viramidine 61 Xcellerated T Cells 61 AVE# 61 VitiGam 61 ALN VSP 61 Zelrix 61 Voreloxin 61 T Pred 61 atrasentan 61 palifosfamide 61 Dendreon Provenge 61 XL# XL# XL# XL# 61 velafermin 61 oral taxane 61 ATPace TM 61 atacicept 61 Acetavance 61 Clofarabine 61 ZK EPO 61 evaluating tivozanib 61 Soliris TM eculizumab 61 decitabine 61 eculizumab 61 Cutaneous T 61 MGd 61 Chrysalin 61 Amplimexon 61 Omacetaxine 61 Hepatocellular Carcinoma HCC 61 refractory cutaneous T 61 Ophena 61 Elotuzumab 61 Seliciclib 61 Allovectin 7 61 RH1 61 PROVENGE ® 61 BEMA TM Fentanyl 61 metastatic sarcomas 61 sorafenib tablets 61 Cethrin 61 Phase 2a trial 61 Virulizin ® 61 severe hypercholesterolemia 61 CD# antibody [001] 61 Entereg R 61 ZEVALIN ® 61 vascular disrupting agent 61 peginesatide 61 TACI Ig 61 veltuzumab 61 Bronchitol 61 Vectibix panitumumab 61 IoGen 61 ONTAK 61 HQK 61 Carfilzomib 61 anti leukemic 61 Campath ® 61 Nexavar sorafenib 61 NGX# 61 myelodysplastic syndromes MDS 61 Targretin capsules 61 reslizumab 60 histamine dihydrochloride 60 docetaxel Taxotere ® 60 voclosporin 60 histone deacetylase HDAC inhibitor 60 leading oral taxane 60 refractory acute myeloid 60 HuMax TAC 60 liprotamase 60 imetelstat 60 JAK2 inhibitor 60 dalbavancin 60 lumiliximab 60 Resten NG 60 ELADUR 60 metastatic hormone refractory 60 Picoplatin 60 PSMA ADC 60 Corlux 60 Revimmune 60 Telavancin 60 ZADAXIN ® 60 Defibrotide 60 hormone refractory prostate cancer 60 ProLindac 60 Viprinex 60 Genasense ® oblimersen 60 Glybera 60 maraviroc 60 NEUVENGE 60 fidaxomicin 60 Theratope 60 lintuzumab SGN 60 angiogenesis inhibitor 60 randomized Phase 60 RhuDex ® 60 Cotara 60 anti EGFR antibody 60 APD# 60 L DOS# 60 rhThrombin 60 farletuzumab 60 B CLL 60 REOLYSIN R 60 #ME# 60 Xcytrin R 60 BENLYSTA ® 60 denufosol 60 StemEx 60 dasatinib Sprycel ® 60 Aplidin 60 Cloretazine ® 60 azacitidine 60 ONCONASE 60 Intravenous CP 60 diabetic neuropathic pain 60 CCX# 60 MyVax personalized immunotherapy 60 ProSavin 60 Tesetaxel 60 ganaxolone 60 systemic anaplastic large 60 imatinib Gleevec ® 60 Omapro 60 SNT MC# 60 cutaneous T 60 chemotherapy induced neutropenia 60 KNS # 60 iclaprim 60 XL# anticancer compounds 60 MYLOTARG 60 favorable pharmacokinetic profile 60 Voraxaze ™ 60 Ixempra 60 NeuroVax TM 60 adipiplon 60 PEG Interferon lambda 60 CINTREDEKIN BESUDOTOX 60 EGFR expressing mCRC 60 pexiganan 60 motexafin gadolinium Injection 60 rALLy clinical trial 60 therapeutic monoclonal antibody 60 CRMD# 60 multicenter Phase II 60 TBC# 60 ABRAXANE ® 60 Altropane 60 triphendiol 60 GAP #B# 60 cetuximab Erbitux R 60 Lenocta 60 BEMA Granisetron 60 VAPRISOL 60 relapsed leukemia 60 vernakalant oral 60 Torisel 60 efaproxiral 60 RSD# 60 GW# [003] 60 Reverset 60 oral antiviral 60 Excellarate 60 GAMMAGARD 60 Androxal TM 60 Onconase 60 Guanilib 60 EOquin TM 60 Zytiga 60 Phase #b/#a 60 orally bioavailable 60 relapsed ovarian cancer 60 Clavis Pharma 60 histone deacetylase inhibitor 60 ThermoDox ® 60 Troxatyl TM 60 HCV protease inhibitor 60 AEGR 60 sBLA 60 anidulafungin 60 Tavocept 60 Taxotere R 60 oral gallium 60 Revlimid lenalidomide 60 ZEVALIN 60 humanized anti 60 aleglitazar 60 Fx #A 60 Aflibercept 60 ENMD # 60 ARIKACE ™ 60 PSN# [002] 60 IMC #B 60 ANYARA 60 AZILECT ® 60 lapatinib 60 GLP toxicology studies 60 ARIKACE 60 DPX Survivac 60 ALN PCS 60 Camvia 60 ThermoDox R 60 Tezampanel 60 Nuvion 60 Pirfenidone 60 pharmacokinetic PK study 60 gefitinib Iressa 60 InSite Vision 60 Laquinimod 60 DXL# 60 pegloticase 60 LE DT 60 Ophena TM 60 AZD# 60 R#/MEM # 60 Cannabinor 60 pazopanib 60 Pazopanib 60 prostate cancer CRPC 60 AzaSite Xtra 60 Ceflatonin R 60 rALLy trial 60 pirfenidone 60 hematologic malignancies 60 IMiDs 60 Canvaxin 60 tyrosine kinase inhibitor 60 TRISENOX ® 60 AVN# [001] 60 Increlex R 60 Celgene Revlimid 60 dextromethorphan quinidine 60 relapsing remitting multiple sclerosis 60 vilazodone 60 Phase 1b 60 isoform selective 60 interferon gamma 1b 60 UVIDEM 60 HuCNS SC cells 60 Telatinib 60 figitumumab 60 randomized Phase 2b 60 VIDAZA 60 NVA# 60 DR Cysteamine 60 Plenaxis TM 60 investigational antiplatelet agent 60 ApoB SNALP 60 TOLAMBA 60 epigenetic therapies 60 evaluating satraplatin 60 velafermin belinostat 60 Modrenal R 60 Trastuzumab 60 DU #b 60 HCV protease 60 BLP# Liposome Vaccine 60 omega interferon 60 BLA submission 60 Kamada AAT 60 ENRICH trial 60 Neuvenge 60 Hedgehog Pathway Inhibitor 60 Satraplatin 60 rituximab Rituxan 60 MNTX 60 Davanat 60 Dapagliflozin 60 lucinactant 60 palifosfamide Zymafos TM 60 ThermoDox 60 Elagolix 60 naronapride 60 Golimumab 60 Vitaxin 60 Phase Ib II 60 Imprime PGG 60 Ferumoxytol 60 Litx 59 Indaflex TM 59 Phase 2b study 59 omacetaxine mepesuccinate 59 anticancer agent 59 ADVEXIN clinical 59 VELCADE 59 pegfilgrastim 59 taliglucerase alfa 59 ISIS # 59 ongoing Phase IIIb 59 Solazed TM 59 MabCampath 59 telaprevir 59 Valortim 59 orBec R 59 vascular disrupting agents 59 DPP4 59 oral deforolimus 59 refractory indolent non 59 biologic therapy 59 chemotherapeutic drug 59 Nabi HB Intravenous 59 IgG1 monoclonal antibody 59 mipomersen 59 MultiStem 59 anticancer therapy 59 Alzhemed TM 59 eritoran 59 MT# MEDI 59 refractory peripheral T 59 Octreolin 59 Onco TCS 59 motesanib 59 platinum refractory 59 sipuleucel T 59 OMNARIS HFA 59 perifosine KRX 59 refractory gout 59 BrachySil 59 velaglucerase alfa 59 DAVANAT ® 59 sargramostim 59 Tarmogen 59 sNDA submission 59 linaclotide 59 NV1FGF 59 tgAAC# 59 IAP inhibitor 59 Biologics License Application 59 bortezomib Velcade 59 Anturol TM 59 Vernakalant 59 VNP#M 59 Phase #b/#a clinical 59 BEXXAR 59 ocular formulation 59 proteasome inhibitor bortezomib 59 relapsed SCLC 59 oral salmon calcitonin 59 oral picoplatin 59 cilengitide 59 GRNVAC1 59 Gleevec Glivec 59 Exelbine 59 olaparib 59 Irinotecan 59 TRIOLEX 59 mTOR inhibitor 59 Riquent 59 EP #R 59 pemetrexed Alimta 59 Panitumumab 59 trastuzumab Herceptin 59 Neulasta ® 59 Phase IIB 59 hoFH 59 FOLFOX6 chemotherapy regimen 59 targeting CD# 59 Pixuvri 59 panitumumab Vectibix 59 TORISEL 59 BioNumerik 59 pivotal Phase III 59 MoxDuo IR 59 Gliadel Wafer 59 tezampanel NGX# 59 docetaxel chemotherapy 59 tramiprosate 59 sapacitabine CYC# 59 delivers fluocinolone acetonide FA 59 Phase 1b clinical 59 dexanabinol 59 THR beta agonist 59 oxaliplatin Eloxatin 59 adecatumumab MT# 59 sorafenib 59 Removab 59 LAF# 59 metastatic castration resistant 59 PRTX 59 oxymorphone ER 59 CTAP# Capsules 59 mitogen activated ERK kinase 59 Xyotax 59 posaconazole 59 Emezine 59 ustekinumab 59 pseudobulbar affect PBA 59 ONCASPAR 59 Sudhir Agrawal D.Phil 59 CRx 59 MAXY alpha 59 Vaprisol 59 investigational drug 59 pradefovir 59 Fludara ® 59 regorafenib 59 Zelapar 59 AGGRASTAT ® 59 Xerecept 59 TRIOLEX HE# APOPTONE HE# 59 Angiocept 59 Actimmune ® 59 Anturol ® 59 Serdaxin 59 TroVax 59 AeroLEF TM 59 LHRH antagonist 59 Phase IIb clinical trials 59 cabozantinib 59 Actemra tocilizumab 59 PCK# 59 Afinitor 59 OMP #R# 59 CD# monoclonal antibody 59 Genasense R oblimersen 59 TAFA# 59 dasatinib 59 ocrelizumab 59 volociximab 59 MYDICAR 59 HERmark 59 recurrent ovarian cancer 59 PROSTVAC TM 59 ularitide 59 Locteron ® 59 rFIXFc 59 ZYBRESTAT fosbretabulin 59 BZL# 59 BiTE R 59 Voraxaze 59 alogliptin 59 seliciclib CYC# 59 metastatic melanoma 59 LEVADEX ™ 59 drug ISA# 59 palifermin 59 Neo Kidney Augment 59 ILUVIEN ® 59 Apoptone 59 rasagiline tablets 59 investigational compound 59 uric acid lowering 59 sodium Injection 59 incyclinide 59 oral methylnaltrexone 59 Provenge sipuleucel T 59 taxane 59 SARMs 59 faropenem medoxomil 59 Gleevec imatinib 59 CDK cyclin dependent 59 Actemra 59 Pfizer Sutent 59 AVASTIN 59 eliglustat tartrate 59 TransVax TM 59 metastatic colorectal cancer 59 gallium nitrate injection 59 PKC# 59 Talabostat 59 galiximab 59 efficacy tolerability 59 PRECISE trial 59 talabostat 59 Soliris eculizumab 59 chemotherapeutic agent 59 Zemiva TM 59 Teysuno 59 metastatic HRPC 59 COPREXA 59 teriflunomide 59 Toctino ® alitretinoin 59 PLX cells 59 Albuferon 59 investigational pan BCR 59 Benlysta belimumab 59 JOULFERON 59 intravenous acetaminophen 59 refractory CTCL 59 bosutinib 59 PHX# 59 orphan medicinal product 59 Tekamlo 59 Generx 59 ferumoxytol 59 EGFR inhibitors 59 Telaprevir 59 Mycamine 59 elvucitabine 59 denosumab 59 Tarceva 59 Cloretazine R 59 FACTIVE R gemifloxacin 59 trastuzumab Herceptin R 59 IMP# 58 nalbuphine ER 58 bortezomib Velcade ® 58 lomitapide 58 Rhucin 58 2 methoxyestradiol 58 Complete Response 58 SPARLON 58 Exalgo TM 58 trastuzumab DM1 58 rindopepimut 58 myelodysplastic syndromes 58 Onbrez Breezhaler 58 novel anticancer 58 Marketing Authorization Application 58 docetaxel 58 NU# [001] 58 ostarine 58 AAG geldanamycin analog 58 ZEGERID Powder 58 SIR Spheres 58 Phase 2b clinical 58 ADVEXIN p# therapy 58 filgrastim 58 CytoFab 58 YONDELIS R 58 Trizytek 58 Mipomersen 58 Uvidem 58 CIMZIA TM 58 NEBIDO 58 tocilizumab 58 WILEX 58 CDP# 58 ToGA 58 Zingo TM 58 Triapine 58 THALOMID 58 REMUNE R 58 octreotide implant 58 prostone 58 Excellagen 58 VPRIV 58 CLIRS trial